<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02324244</url>
  </required_header>
  <id_info>
    <org_study_id>MICRO.HGUGM.2014-006</org_study_id>
    <nct_id>NCT02324244</nct_id>
  </id_info>
  <brief_title>CMV Intensive Care Units</brief_title>
  <official_title>A Prospective Monitoring Study of Cytomegalovirus Infection in Immunocompetent Critical Heart Surgery Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emilio Bouza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Gregorio Mara単on</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospectively assessment of CMV viremia by real-time polymerase chain reaction (PCR) in a
      broad cohort of consecutive immunocompetent adults admitted to a major heart surgery
      intensive care unit (MHS-ICU) with the goal of determining the epidemiology, risk factors,
      and clinical significance of CMV infection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence number of participants with a positive CMV positive result</measure>
    <time_frame>month 8</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>risk factors for CMV reactivation</measure>
    <time_frame>month 8</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality by day 30</measure>
    <time_frame>month 8</time_frame>
    <description>composite endpoint. hospitalization or death by day 30</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prolonged hospitalization . More than 30 days</measure>
    <time_frame>month 8</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">150</enrollment>
  <condition>CMV Infection</condition>
  <arm_group>
    <arm_group_label>immunocompetent patients underwent heart surgery</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        immunocompetent adults admitted to a major heart surgery intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Agreeing to participate in the study

          -  Age of at least 18 years

          -  Admission to the MHS-ICU for at least 72 hours

        Exclusion Criteria:

          -  Inability to give informed consent

          -  Age younger than 18 years

          -  AIDS

          -  Pregnancy

          -  Organ or bone marrow transplant, receipt of immunosuppressive therapy including
             corticosteroids within 30 days, and cancer or hematologic malignancy treated with
             radiotherapy or chemotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Mu単oz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Gregorio Mara単on</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Servicio de Microbiologia y Enfermedades Infecciosas</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2014</study_first_submitted>
  <study_first_submitted_qc>December 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2014</study_first_posted>
  <last_update_submitted>December 23, 2014</last_update_submitted>
  <last_update_submitted_qc>December 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Mara単on</investigator_affiliation>
    <investigator_full_name>Emilio Bouza</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <keyword>Cytomegalovirus</keyword>
  <keyword>critical patient</keyword>
  <keyword>ICU</keyword>
  <keyword>immunocompetent</keyword>
  <keyword>clinical suspicion</keyword>
  <keyword>risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Cytomegalovirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

